Insect cell-expressed p180erbB3 possesses an impaired tyrosine kinase activity.
about
Neuregulin-4: a novel growth factor that acts through the ErbB-4 receptor tyrosine kinaseInteraction between protein tyrosine phosphatase and protein tyrosine kinase is involved in androgen-promoted growth of human prostate cancer cellsUnique carboxyl-terminal sequences of wild type and alternatively spliced variant forms of transforming growth factor-alpha precursors mediate specific interactions with ErbB4 and ErbB2An RBCC protein implicated in maintenance of steady-state neuregulin receptor levelsIdentification of a region within the ErbB2/HER2 intracellular domain that is necessary for ligand-independent associationHeregulin-dependent regulation of HER2/neu oncogenic signaling by heterodimerization with HER3Association of csk-homologous kinase (CHK) (formerly MATK) with HER-2/ErbB-2 in breast cancer cellsRequirement of ErbB2 for signalling by interleukin-6 in prostate carcinoma cellsAnalysis of Grb7 recruitment by heregulin-activated erbB receptors reveals a novel target selectivity for erbB3Epigen, the last ligand of ErbB receptors, reveals intricate relationships between affinity and mitogenicityOverexpression of an enzymically inactive interleukin-1-receptor-associated kinase activates nuclear factor-kappaBEpidermal growth factor and betacellulin mediate signal transduction through co-expressed ErbB2 and ErbB3 receptorsErk5 participates in neuregulin signal transduction and is constitutively active in breast cancer cells overexpressing ErbB2ErbB3/HER3 intracellular domain is competent to bind ATP and catalyze autophosphorylationExpression of HER3, HER4 and their ligand heregulin-4 is associated with better survival in bladder cancer patientsSuppression of cell growth and invasion by miR-205 in breast cancerA hierarchical network of interreceptor interactions determines signal transduction by Neu differentiation factor/neuregulin and epidermal growth factorInteraction of the PA2G4 (EBP1) protein with ErbB-3 and regulation of this binding by heregulinThe ErbB2/ErbB3 heterodimer functions as an oncogenic unit: ErbB2 requires ErbB3 to drive breast tumor cell proliferationNeuregulin-induced ErbB3 downregulation is mediated by a protein stability cascade involving the E3 ubiquitin ligase Nrdp1Essential function for ErbB3 in breast cancer proliferationTyrosine kinase signalling in breast cancer: ErbB family receptor tyrosine kinasesDual activation of pathways regulated by steroid receptors and peptide growth factors in primary prostate cancer revealed by Factor Analysis of microarray data.Profile of panitumumab as first-line treatment in patients with wild-type KRAS metastatic colorectal cancerHuman epidermal growth factor receptor signaling in acute lung injuryA MultiSite Gateway Toolkit for Rapid Cloning of Vertebrate Expression Constructs with Diverse Research Applications.Lapatinib Plasma and Tumor Concentrations and Effects on HER Receptor Phosphorylation in TumorStructure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitorThe Juxtamembrane Region of the EGF Receptor Functions as an Activation DomainStructural analysis of the catalytically inactive kinase domain of the human EGF receptor 3Combining lapatinib (GW572016), a small molecule inhibitor of ErbB1 and ErbB2 tyrosine kinases, with therapeutic anti-ErbB2 antibodies enhances apoptosis of ErbB2-overexpressing breast cancer cells.Developmental therapeutics for inflammatory breast cancer: Biology and translational directionsReceptor tyrosine kinase signaling: regulating neural crest development one phosphate at a timeEpidermal growth factor signaling in transformed cellsExpression of the BRK tyrosine kinase in mammary epithelial cells enhances the coupling of EGF signalling to PI 3-kinase and Akt, via erbB3 phosphorylationT-cell-specific expression of kinase-defective Eph-family receptor protein, EphB6 in normal as well as transformed hematopoietic cellsFeedback inhibition by RALT controls signal output by the ErbB networkIdentification of a heregulin binding site in HER3 extracellular domainBinding interaction of the heregulinbeta egf domain with ErbB3 and ErbB4 receptors assessed by alanine scanning mutagenesisMutation of a Shc binding site tyrosine residue in ErbB3/HER3 blocks heregulin-dependent activation of mitogen-activated protein kinase
P2860
Q22009917-B3E041C6-0F92-4AE4-BFD1-BB6A2A068294Q22254244-E249C85A-92C7-4A32-8511-51EC93858A58Q22254700-BC519C94-4139-4025-8DD5-C6FCC4529BA7Q24292374-1ED56C4D-1493-4E25-A7C2-B29A84107828Q24297029-FA0AE469-DDBB-4EB5-8743-2F8FC8B25A77Q24309266-498B6CE8-72F5-4FF0-A9FF-3FFB9D294A9DQ24314260-47DDFE5B-5AD2-46BE-AD30-0F0211D33B86Q24317507-09B364F9-F49D-4A61-9D39-EBE0B006BDF4Q24319261-6D91D407-5A00-4886-8F8A-93EA3777D110Q24324102-92126AA5-8414-4946-94D2-D5092F245C41Q24531441-12A37DFB-002E-4486-BB95-E60A56A2D9AFQ24532786-B008C568-22F5-4C45-9BD8-E4249932F7F2Q24538180-1C9FEEFF-A445-475A-95B8-27CA8D686ABEQ24621754-616C4DA9-76BB-43D7-91B3-7A317B30BC08Q24645597-90269195-FF4B-4507-A6BB-F00F5892AE83Q24647586-E6AC9AD1-F902-49E2-BF8E-57955827266AQ24648517-EDCF2BF0-FC07-4902-BC72-90214B4416CEQ24649294-648687F4-5EB8-4AA1-9469-6CEEBBF14043Q24678674-1FBC0576-9536-42A7-9222-6312DE3F2F99Q24681497-0E3AFEC1-2D20-4F6A-BE1C-FF23E2771697Q24795054-04AF63EB-7063-4118-B977-460B57188368Q24802950-A4BECEBD-A4F9-4277-AE90-4101CA416EAFQ24817218-C8EA559E-00ED-4A88-9108-94F61CE61BFEQ26771952-0BF83BAC-EAAB-44F1-A97A-D6B8F6479B43Q27002075-20D353DA-518B-4997-99C3-AC4EB16000E1Q27334567-3C18AADC-4592-47FE-A048-8ACED50E3C86Q27342948-0221E034-628B-4825-B12A-60E2CA05F3BBQ27639528-600122A8-738A-403C-9F4F-67F22EA7B842Q27646344-3548C898-EE09-4DBF-8419-21DD134847F0Q27646596-E84307FB-2FC6-4383-9611-6B7F47963A38Q27824846-B7D674DF-4EB5-4D4A-990F-BBDEC6A0D5A1Q28075322-D8C47467-F3F6-4B7A-AEAC-0D0CF845D32AQ28083779-AF73DBCF-CB30-429D-A2BC-5BD5597F62E7Q28084034-5C405D4E-7AC3-494D-962A-F03ACB15946CQ28140199-32E2A1D5-B579-4C30-BCD3-40F33A76E829Q28145387-69C6F15C-FC3E-47B3-9B43-C7F3705F30ACQ28183228-C8557ABE-469D-4FAA-B839-CAA1F8CD3BC9Q28216145-9367E364-4609-4985-A3AE-18F11E04247CQ28269163-97E2638A-D0BF-4E0D-9E84-F80981DA9F94Q28278833-ED4195BC-0A3F-48FD-B318-77E78D3F7CC5
P2860
Insect cell-expressed p180erbB3 possesses an impaired tyrosine kinase activity.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Insect cell-expressed p180erbB3 possesses an impaired tyrosine kinase activity.
@ast
Insect cell-expressed p180erbB3 possesses an impaired tyrosine kinase activity.
@en
type
label
Insect cell-expressed p180erbB3 possesses an impaired tyrosine kinase activity.
@ast
Insect cell-expressed p180erbB3 possesses an impaired tyrosine kinase activity.
@en
prefLabel
Insect cell-expressed p180erbB3 possesses an impaired tyrosine kinase activity.
@ast
Insect cell-expressed p180erbB3 possesses an impaired tyrosine kinase activity.
@en
P2093
P2860
P356
P1476
Insect cell-expressed p180erbB3 possesses an impaired tyrosine kinase activity.
@en
P2093
J V Platko
K L Carraway
R A Cerione
P2860
P304
P356
10.1073/PNAS.91.17.8132
P407
P577
1994-08-01T00:00:00Z